|
| Exchange Received Time 15/11/2018 17:34:25 Exchange Disseminated Time 15/11/2018 17:34:30 Time Taken 00:00:05 | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Monday, November 12, 2018 at 02.30 P.M. local time, to discuss the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2018.
Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO, Mr. Sachin Salvi, GM-Finance and Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, represented the Company.
|
|
|